Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors-Reference-Cited by-同舟云学术

Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors

Published:2010-01-22 Issue:2 Volume:130 Page:193-201
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:

Author:

Kumar Rajesh,Bumb Ram A.,Salotra Poonam

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2567.2009.03223.x/fullpdf

Reference44 articles.

1. The current status of zoonotic leishmaniasis and approaches to disease control;Gramiccia;Int J Parasitol,2005

2. Microsatellite analysis reveals genetic structure of Leishmania tropica;Schwenkenbecher;Int J Parasitol,2006

3. Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunological tools;Kumar;Am J Trop Med Hyg,2007

4. Mice from genetically resistant background lacking IFN-γ receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell type-1 CD4+ T cell response;Swihart;J Exp Med,1995

5. Regulation of protective immunity against Leishmania major in mice;Louis;Curr Opin Immunol,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing the efficacy of fluconazole against Leishmania major: Formulation and evaluation of FLZ-nanoemulsions for topical delivery;Biomedicine & Pharmacotherapy;2024-09

2. Evaluation of IL-8, nitric oxide and macrophage inhibitory factor as clinical circulatory markers in patients with cutaneous leishmaniasis, before and during sodium stibogluconate treatment;Cytokine;2024-01

3. TLR-2 agonist Pam3CSK4 has no therapeutic effect on visceral leishmaniasis in BALB/c mice and may enhance the pathogenesis of the disease;Immunobiology;2023-09

4. In vitro evaluation of immunomodulatory activity of the copper(I) complex and Libidibia ferrea in cutaneous leishmaniasis;ACTA BRAS;2023

5. Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani;PLOS ONE;2023-01-05